Alarcan, H.; Chaumond, R.; Emond, P.; Benz-De Bretagne, I.; Lefèvre, A.; Bakkouche, S.-e.; Veyrat-Durebex, C.; Vourc’h, P.; Andres, C.; Corcia, P.;
et al. Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis. Biomolecules 2021, 11, 691.
https://doi.org/10.3390/biom11050691
AMA Style
Alarcan H, Chaumond R, Emond P, Benz-De Bretagne I, Lefèvre A, Bakkouche S-e, Veyrat-Durebex C, Vourc’h P, Andres C, Corcia P,
et al. Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis. Biomolecules. 2021; 11(5):691.
https://doi.org/10.3390/biom11050691
Chicago/Turabian Style
Alarcan, Hugo, Romane Chaumond, Patrick Emond, Isabelle Benz-De Bretagne, Antoine Lefèvre, Salah-eddine Bakkouche, Charlotte Veyrat-Durebex, Patrick Vourc’h, Christian Andres, Philippe Corcia,
and et al. 2021. "Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis" Biomolecules 11, no. 5: 691.
https://doi.org/10.3390/biom11050691
APA Style
Alarcan, H., Chaumond, R., Emond, P., Benz-De Bretagne, I., Lefèvre, A., Bakkouche, S.-e., Veyrat-Durebex, C., Vourc’h, P., Andres, C., Corcia, P., & Blasco, H.
(2021). Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis. Biomolecules, 11(5), 691.
https://doi.org/10.3390/biom11050691
